| 000 | 01576 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515204303.0 | ||
| 264 | 0 | _c20100524 | |
| 008 | 201005s 0 0 eng d | ||
| 022 | _a1437-7772 | ||
| 024 | 7 |
_a10.1007/s10147-009-0015-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIshibashi, Keiichiro | |
| 245 | 0 | 0 |
_aEffect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study. _h[electronic resource] |
| 260 |
_bInternational journal of clinical oncology _cFeb 2010 |
||
| 300 |
_a82-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCalcium _xadministration & dosage |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aEarly Termination of Clinical Trials |
| 650 | 0 | 4 |
_aFluorouracil _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucovorin _xtherapeutic use |
| 650 | 0 | 4 |
_aMagnesium _xadministration & dosage |
| 650 | 0 | 4 | _aNeurotoxicity Syndromes |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadverse effects |
| 650 | 0 | 4 | _aOxaliplatin |
| 700 | 1 | _aOkada, Norimichi | |
| 700 | 1 | _aMiyazaki, Tatsuya | |
| 700 | 1 | _aSano, Motohiko | |
| 700 | 1 | _aIshida, Hideyuki | |
| 773 | 0 |
_tInternational journal of clinical oncology _gvol. 15 _gno. 1 _gp. 82-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10147-009-0015-3 _zAvailable from publisher's website |
| 999 |
_c19483103 _d19483103 |
||